United Kingdom Bioprocess Monitoring Market Size, Share, and COVID-19 Impact Analysis, By Application (Mycoplasma Detection, Host Cell Residual DNA/Protein Quantitation, Viral Titer Determination, Adventitious Virus Testing, and Other Applications), By End Use (Pharmaceutical & Biotechnology Companies, CMOs & CROs, and Academic & Research Institutes), and United Kingdom Bioprocess Monitoring Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Bioprocess Monitoring Market Size Insights Forecasts s2035

• The United Kingdom Bioprocess Monitoring Market Size was estimated at USD 186.56 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 10.10% from 2025 to 2035
• The United Kingdom Bioprocess Monitoring Market Size is Expected to Reach USD 537.45 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the United Kingdom Bioprocess Monitoring Market Size is anticipated to reach USD 537.45 Million by 2035, growing at a CAGR of 10.10% from 2025 to 2035. Further encouraging innovation and growth in the bioprocess monitoring sector have been government initiatives and funding for biotechnology research. Government, industry, and academics collaborate to develop and commercialize cutting-edge technology.

Market Overview

The United Kingdom bioprocess monitoring market refers to the subsegment focused on the production and application of the technologies and systems used to track, measure, and control biological processes in real time, especially during the production of biopharmaceuticals, vaccines, and cell or gene therapies. With the growing market for innovative and efficient biopharmaceutical products, including vaccines, recombinant proteins, and monoclonal antibodies, more precise and reliable bioprocess monitoring tools are needed. The market expansion for bioprocess monitoring has been significantly aided by the biotechnology industry's explosion in research and development (R&D). This increase in funding and innovation has led to the creation of innovative instruments and techniques that have fundamentally altered the way bioprocesses are seen and controlled. The advanced tools and methods that enable accurate and efficient measurement of several parameters during the production of biological products have led to a recent surge in the bioprocess monitoring market.

Report Coverage

This research report categorizes the market for the United Kingdom bioprocess monitoring market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom bioprocess monitoring market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom bioprocess monitoring market.

Driving Factors

The market for United Kingdom bioprocess monitoring is driven by the market expansion for bioprocess monitoring has been significantly aided by the biotechnology industry's explosion in research and development (R&D). This increase in funding and innovation has led to the creation of innovative instruments and techniques that have fundamentally altered the way bioprocesses are seen and controlled. The advanced tools and methods that enable accurate and efficient measurement of several parameters during the production of biological products have led to a recent surge in the bioprocess monitoring market.

Restraining Factors

The UK bioprocess monitoring market is constrained by a number of constraints, such as high expense, and the intricacy of sophisticated monitoring systems is a major obstacle that may discourage adoption, especially among small and mid-sized biotech companies.

Market Segmentation

The United Kingdom bioprocess monitoring market share is classified into application, and end use.

• The host cell residual DNA/protein quantitation segment held the largest share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The United Kingdom bioprocess monitoring market is segmented by application into mycoplasma detection, host cell residual DNA/protein quantitation, viral titer determination, adventitious virus testing, and other applications. Among these, the host cell residual DNA/protein quantitation segment held the largest share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. This cutting-edge test produces precise results in a matter of minutes and is quick and easy to administer. It makes use of an enhanced PCR method. Recent developments in technology, such as PCR-based testing and sophisticated culture techniques, are improving the sensitivity and precision of mycoplasma identification. These developments could improve bioprocessing workflows and guarantee product safety, which will drive the mycoplasma detection market's growth.

• The CMOS & CROS segment held a significant share in 2024 and is expected to grow at a rapid pace over the forecast period.

The United Kingdom bioprocess monitoring market is divided by end use into pharmaceutical & biotechnology companies, CMOS & CROS, and academic & research institutes. Among these, the CMOS & CROS segment held a significant share in 2024 and is expected to grow at a rapid pace over the forecast period. This is because the need for advanced bioprocess monitoring systems has also grown as a result of the development of complex biologics and the growing focus on tailored therapy. CROs and CMOs are crucial in addressing these problems because they leverage their resources and expertise to support the growth of the biopharmaceutical industry.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom bioprocess monitoring market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Eppendorf UK
• Syrris Ltd
• IS Instruments Ltd
• CPI
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom bioprocess monitoring market based on the below-mentioned segments:

United Kingdom Bioprocess Monitoring Market, By Application

• Mycoplasma Detection
• Host Cell Residual DNA/Protein Quantitation
• Viral Titer Determination
• Adventitious Virus Testing
• Other Applications

United Kingdom Bioprocess Monitoring Market, By End Use

• Pharmaceutical & Biotechnology Companies
• CMOs & CROs
• Academic & Research Institutes